A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection. (2022)
Attributed to:
VAccine deveLopment for complex Intracellular neglecteD pAThogEns (VALIDATE)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/vaccines10071146
PubMed Identifier: 35891310
Publication URI: http://europepmc.org/abstract/MED/35891310
Type: Journal Article/Review
Volume: 10
Parent Publication: Vaccines
Issue: 7
ISSN: 2076-393X